From cancer research to cure
Eli Lilly & Company in the IMPRESS study
Eli Lilly & Company is now part of the national Norwegian IMPRESS study.
LATEST NEWS
Lite satsing på kreftinnovasjon
Statsbudsjettet for 2022 inneholder lite for kreftpasienter og innovasjon innen kreftbehandling.
Brett Jordan/ UnsplashOur role as Changemaker
Did you know that Oslo Cancer Cluster is a changemaker?
Clay Banks / UnsplashNOK 16 million to new RWE company
The Research Council of Norway recently awarded grants to several innovation projects in the industrial sector. One of the lucky companies was the newcomer NordicRWE.
Tweets
Videos
We regularly publish new videos to our YouTube channel. Please subscribe to stay up-to-date via the link below.
MEMBERS OF OSLO CANCER CLUSTER
EVENTS
Follow us on Facebook
CONTACT
Info
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.
